Biomea Fusion is trading at $0.63, up 7.74% in pre-market, with no company-specific announcement explaining the October 23 rise identified in available coverage. - Its latest notable company news was Phase 1 BMF-650 results announced October 13, not a new October 23 catalyst. - The prior session’s risk-off backdrop included concerns about AI spending and higher oil prices, but available information does not establish these as the reason for the pre-market gain. - Pre-market volume and activity details were unavailable.